Sheep and goat BSE propagate more efficiently than cattle BSE in human PrP transgenic mice

Danielle Padilla, Vincent Béringue, Juan Carlos Espinosa, Olivier Andreoletti, Emilie Jaumain, Fabienne Reine, Laetitia Herzog, Alfonso Gutierrez-Adan, Belen Pintado, Hubert Laude, Juan Maria Torres, Danielle Padilla, Vincent Béringue, Juan Carlos Espinosa, Olivier Andreoletti, Emilie Jaumain, Fabienne Reine, Laetitia Herzog, Alfonso Gutierrez-Adan, Belen Pintado, Hubert Laude, Juan Maria Torres

Abstract

A new variant of Creutzfeldt Jacob Disease (vCJD) was identified in humans and linked to the consumption of Bovine Spongiform Encephalopathy (BSE)-infected meat products. Recycling of ruminant tissue in meat and bone meal (MBM) has been proposed as origin of the BSE epidemic. During this epidemic, sheep and goats have been exposed to BSE-contaminated MBM. It is well known that sheep can be experimentally infected with BSE and two field BSE-like cases have been reported in goats. In this work we evaluated the human susceptibility to small ruminants-passaged BSE prions by inoculating two different transgenic mouse lines expressing the methionine (Met) allele of human PrP at codon 129 (tg650 and tg340) with several sheep and goat BSE isolates and compared their transmission characteristics with those of cattle BSE. While the molecular and neuropathological transmission features were undistinguishable and similar to those obtained after transmission of vCJD in both transgenic mouse lines, sheep and goat BSE isolates showed higher transmission efficiency on serial passaging compared to cattle BSE. We found that this higher transmission efficiency was strongly influenced by the ovine PrP sequence, rather than by other host species-specific factors. Although extrapolation of results from prion transmission studies by using transgenic mice has to be done very carefully, especially when human susceptibility to prions is analyzed, our results clearly indicate that Met129 homozygous individuals might be susceptible to a sheep or goat BSE agent at a higher degree than to cattle BSE, and that these agents might transmit with molecular and neuropathological properties indistinguishable from those of vCJD. Our results suggest that the possibility of a small ruminant BSE prion as vCJD causal agent could not be ruled out, and that the risk for humans of a potential goat and/or sheep BSE agent should not be underestimated.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1. Comparative PrP res content of…
Figure 1. Comparative PrPres content of the cattle, sheep and goat isolates used for tgHu bioassays.
Immunoblots of brain PrPres detected with SHA 31 mAb. Direct sample and 1/5 dilutions were loaded on 12% Bis-Tris gels. Molecular weights (in kDa) are shown at the left side of the blot. Excluding the BSE0 isolate, all cattle BSE isolates presented higher PrPres contents than the sheep and goat BSE isolates. Cattle BSE2 and BSE3 isolates presented comparable PrPres contents while that in the BSE0 isolate was substantially lower. The sheep and goat BSE isolates used contained similar PrPres quantity.
Figure 2. Western blots analysis of PrP…
Figure 2. Western blots analysis of PrPres in the brains of tg650 mice infected with human, bovine, ovine and goat isolates.
Immunoblots of brain PrPres detected with SHA 31 Mab. Similar amount of brain tissue equivalent (20 µg) was loaded for adequate comparison. vCJD isolate was loaded for comparison. Molecular weights (in kDa) are shown at the left side of the blot. Similar PrPres banding patterns were observed in the vCJD- and the cattle, sheep and goat BSE-challenged tg650 mice.
Figure 3. Western blots analysis of PrP…
Figure 3. Western blots analysis of PrPres in the brains of tg340 mice infected with human, bovine, ovine and goat isolates.
Immunoblots of brain PrPres detected with SHA 31 Mab. Similar quantities of PrPres were loaded for adequate comparison. sCJD and vCJD1 isolates were loaded for comparison. Molecular weights (in kDa) are shown at the left side of the blot. Note the typical PrPvCJD banding pattern, characterized by low size fragments and prominent diglycosylated species in the cattle, sheep and goat BSE-challenged mice. These banding patterns clearly differed from that observed after inoculation of mice with sporadic CJD.
Figure 4. Western blots analysis of PrP…
Figure 4. Western blots analysis of PrPres in the brains of tg340 mice infected with human, bovine and ovine isolates.
Immunoblots of brain PrPres detected with SHA 31 and 12B2 mAbs. Similar quantities of PrPres were loaded for adequate comparison. sCJD and vCJD1 isolates were loaded for comparison. Molecular weights (in kDa) are shown at the left side of the blot. Both vCJD- and type I sCJD-like PrPres were observed after second passage of Ca-BSE2 in tg340 mice (Ca-BSE2/Tg340 2P-b and Ca-BSE2/Tg340 2P-a respectively).
Figure 5. Regional distribution of PrP res…
Figure 5. Regional distribution of PrPres in the brain of human PrP transgenic mice infected with BSE agent passaged through sheep, goat or human species.
Histoblots of 4 representative anteroposterior mouse brain sections are shown. Comparison has been made at 3rd passage in tg650 mice. The patterns produced by sheep, goat and cattle BSE and variant CJD appear similar.
Figure 6. Brain vacuolar changes and amyloid…
Figure 6. Brain vacuolar changes and amyloid plaques in transgenic mice for the human PRNP gene (methionine 129 variant - tg650).
Hemalun-Eosin staining. Mice were inoculated with natural goat BSE (a – Bar 150 µm), cattle BSE (b: bar150 µm-e: bar 50 µm), vCJD (c: bar 150 µm-d: bar 50 µm) or experimental BSE in sheep (ARQ/ARQ genotype) (f: bar 50 µm). Vacuolar changes are associates to plaques deposits (a–b–c) (in a *: plaques deposits). Plaques deposits often harboured typical features of florid plaques: presence of crown of vacuoles and glial cell nuclei (d–e–f).
Figure 7. Transmission to human PrP mice…
Figure 7. Transmission to human PrP mice of different BSE isolates generated by intermediary passages in either ovine or bovine PrP transgenic mice.
na: not available (experiments still ongoing). aIntracerebral inoculation with 2 mg brain tissue equivalent; n/n0: diseased, PrPres positive/inoculated animals. cTwo serial passages on tgBov mice.
Figure 8. Brain PrP C expression in…
Figure 8. Brain PrPC expression in homozygous tg340 mouse line in comparison to both tg650 mice and human brain.
A) Immunoblots of the brain PrPC expression in tg340 detected with Pri 308 Mab. Direct sample (10% brain homogenates) and ¼ dilutions were loaded on 12% Bis-Tris gels. The figure illustrates a representative set of three independent experiments. B) Brain PrPC expression in tg340 in comparison to tg650 detected with Pri 308 Mab. Inmunoblots illustrates a representative set of three independent experiments and the diagrams represent the mean densytometric values data from these experiments. Data from human brains (Human) were considered as 1 relative unit. Error bars represent the standard deviation of the mean values.

References

    1. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science. 1982;216:136–144.
    1. Griffith JS. Self-replication and scrapie. Nature. 1967;215:1043–1044.
    1. Wells GA, Scott AC, Johnson CT, Gunning RF, Hancock RD, et al. A novel progressive spongiform encephalopathy in cattle. Vet Rec. 1987;121:419–420.
    1. Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, et al. Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent. Nature. 1997;389:498–501.
    1. Hill AF, Desbruslais M, Joiner S, Sidle KC, Gowland I, et al. The same prion strain causes vCJD and BSE. Nature. 1997;389:526.
    1. Baylis M, Houston F, Kao RR, McLean AR, Hunter N, et al. BSE - a wolf in sheep's clothing? Trends Microbiol. 2002;10:563–570.
    1. Foster JD, Hope J, Fraser H. Transmission of bovine spongiform encephalopathy to sheep and goats. Vet Rec. 1993;133:339–341.
    1. Bellworthy SJ, Dexter G, Stack M, Chaplin M, Hawkins SA, et al. Natural transmission of BSE between sheep within an experimental flock. Vet Rec. 2005;157:206.
    1. Bellworthy SJ, Dexter G, Stack M, Chaplin M, Hawkins SA, et al. Oral transmission of BSE to VRQ/VRQ sheep in an experimental flock. Vet Rec. 2008;162:130–131.
    1. Stack M, Gonzalez L, Jeffrey M, Martin S, Macaldowie C, et al. Three serial passages of bovine spongiform encephalopathy in sheep do not significantly affect discriminatory test results. J Gen Virol. 2009;90:764–768.
    1. Houston F, Goldmann W, Chong A, Jeffrey M, Gonzalez L, et al. Prion diseases: BSE in sheep bred for resistance to infection. Nature. 2003;423:498.
    1. Eloit M, Adjou K, Coulpier M, Fontaine JJ, Hamel R, et al. BSE agent signatures in a goat. Vet Rec. 2005;156:523–524.
    1. Jeffrey M, Martin S, Gonzalez L, Foster J, Langeveld JP, et al. Immunohistochemical features of PrP(d) accumulation in natural and experimental goat transmissible spongiform encephalopathies. J Comp Pathol. 2006;134:171–181.
    1. Wells GA, Hawkins SA, Green RB, Austin AR, Dexter I, et al. Preliminary observations on the pathogenesis of experimental bovine spongiform encephalopathy (BSE): an update. Vet Rec. 1998;142:103–106.
    1. Buschmann A, Groschup MH. Highly bovine spongiform encephalopathy-sensitive transgenic mice confirm the essential restriction of infectivity to the nervous system in clinically diseased cattle. J Infect Dis. 2005;192:934–942.
    1. Wells GA, Spiropoulos J, Hawkins SA, Ryder SJ. Pathogenesis of experimental bovine spongiform encephalopathy: preclinical infectivity in tonsil and observations on the distribution of lingual tonsil in slaughtered cattle. Vet Rec. 2005;156:401–407.
    1. Espinosa JC, Morales M, Castilla J, Rogers M, Torres JM. Progression of prion infectivity in asymptomatic cattle after oral bovine spongiform encephalopathy challenge. J Gen Virol. 2007;88:1379–1383.
    1. Foster JD, Bruce M, McConnell I, Chree A, Fraser H. Detection of BSE infectivity in brain and spleen of experimentally infected sheep. Vet Rec. 1996;138:546–548.
    1. Bellworthy SJ, Hawkins SA, Green RB, Blamire I, Dexter G, et al. Tissue distribution of bovine spongiform encephalopathy infectivity in Romney sheep up to the onset of clinical disease after oral challenge. Vet Rec. 2005;156:197–202.
    1. Collinge J, Clarke AR. A general model of prion strains and their pathogenicity. Science. 2007;318:930–936.
    1. Pattison IH. The relative susceptibility of sheep, goats and mice to two types of the goat scrapie agent. Res Vet Sci. 1966;7:207–212.
    1. Scott M, Foster D, Mirenda C, Serban D, Coufal F, et al. Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell. 1989;59:847–857.
    1. Prusiner SB, Scott M, Foster D, Pan KM, Groth D, et al. Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell. 1990;63:673–686.
    1. Peretz D, Williamson RA, Legname G, Matsunaga Y, Vergara J, et al. A change in the conformation of prions accompanies the emergence of a new prion strain. Neuron. 2002;34:921–932.
    1. Collinge J, Sidle KC, Meads J, Ironside J, Hill AF. Molecular analysis of prion strain variation and the aetiology of ‘new variant’ CJD. Nature. 1996;383:685–690.
    1. Scott MR, Will R, Ironside J, Nguyen HO, Tremblay P, et al. Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proc Natl Acad Sci U S A. 1999;96:15137–15142.
    1. Scott MR, Peretz D, Nguyen HO, Dearmond SJ, Prusiner SB. Transmission barriers for bovine, ovine, and human prions in transgenic mice. J Virol. 2005;79:5259–5271.
    1. Nonno R, Di Bari MA, Cardone F, Vaccari G, Fazzi P, et al. Efficient transmission and characterization of Creutzfeldt-Jakob disease strains in bank voles. PLoS Pathog. 2006;2:e12.
    1. Espinosa JC, Andreoletti O, Castilla J, Herva ME, Morales M, et al. Sheep-passaged bovine spongiform encephalopathy agent exhibits altered pathobiological properties in bovine-PrP transgenic mice. J Virol. 2007;81:835–843.
    1. Espinosa JC, Herva ME, Andreoletti O, Padilla D, Lacroux C, et al. Transgenic mice expressing porcine prion protein resistant to classical scrapie but susceptible to sheep bovine spongiform encephalopathy and atypical scrapie. Emerg Infect Dis. 2009;15:1214–1221.
    1. Palmer MS, Dryden AJ, Hughes JT, Collinge J. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature. 1991;352:340–342.
    1. Windl O, Dempster M, Estibeiro JP, Lathe R, de Silva R, et al. Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene. Hum Genet. 1996;98:259–264.
    1. Collinge J. Human prion diseases and bovine spongiform encephalopathy (BSE). Hum Mol Genet. 1997;6:1699–1705.
    1. Lee HS, Brown P, Cervenakova L, Garruto RM, Alpers MP, et al. Increased susceptibility to Kuru of carriers of the PRNP 129 methionine/methionine genotype. J Infect Dis. 2001;183:192–196.
    1. Beringue V, Le Dur A, Tixador P, Reine F, Lepourry L, et al. Prominent and persistent extraneural infection in human PrP transgenic mice infected with variant CJD. PLoS One. 2008;3:e1419.
    1. Beringue V, Herzog L, Reine F, Le Dur A, Casalone C, et al. Transmission of atypical bovine prions to mice transgenic for human prion protein. Emerg Infect Dis. 2008;14:1898–1901.
    1. Yull HM, Ritchie DL, Langeveld JP, van Zijderveld FG, Bruce ME, et al. Detection of type 1 prion protein in variant Creutzfeldt-Jakob disease. Am J Pathol. 2006;168:151–157.
    1. Fraser H, Dickinson AG. Scrapie in mice. Agent-strain differences in the distribution and intensity of grey matter vacuolation. J Comp Pathol. 1973;83:29–40.
    1. Kupfer L, Eiden M, Buschmann A, Groschup MH. Amino acid sequence and prion strain specific effects on the in vitro and in vivo convertibility of ovine/murine and bovine/murine prion protein chimeras. Biochim Biophys Acta. 2007;1772:704–713.
    1. Asante EA, Linehan JM, Desbruslais M, Joiner S, Gowland I, et al. BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. Embo J. 2002;21:6358–6366.
    1. Kong Q, Zheng M, Casalone C, Qing L, Huang S, et al. Evaluation of the human transmission risk of an atypical bovine spongiform encephalopathy prion strain. J Virol. 2008;82:3697–3701.
    1. Bishop MT, Hart P, Aitchison L, Baybutt HN, Plinston C, et al. Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol. 2006;5:393–398.
    1. Beringue V, Andreoletti O, Le Dur A, Essalmani R, Vilotte JL, et al. A bovine prion acquires an epidemic bovine spongiform encephalopathy strain-like phenotype on interspecies transmission. J Neurosci. 2007;27:6965–6971.
    1. Gonzalez L, Chianini F, Martin S, Siso S, Gibbard L, et al. Comparative titration of experimental ovine BSE infectivity in sheep and mice. J Gen Virol. 2007;88:714–717.
    1. Tamguney G, Miller MW, Giles K, Lemus A, Glidden DV, et al. Transmission of scrapie and sheep-passaged bovine spongiform encephalopathy prions to transgenic mice expressing elk prion protein. J Gen Virol. 2009;90:1035–1047.
    1. Tixador P, Herzog L, Reine F, Jaumain E, Chapuis J, et al. The physical relationship between infectivity and prion protein aggregates is strain-dependent. PLoS Pathog. 2010;6:e1000859.
    1. Li J, Browning S, Mahal SP, Oelschlegel AM, Weissmann C. Darwinian evolution of prions in cell culture. Science. 2010;327:869–872.
    1. Baron TG, Madec JY, Calavas D, Richard Y, Barillet F. Comparison of French natural scrapie isolates with bovine spongiform encephalopathy and experimental scrapie infected sheep. Neurosci Lett. 2000;284:175–178.
    1. Jeffrey M, Ryder S, Martin S, Hawkins SA, Terry L, et al. Oral inoculation of sheep with the agent of bovine spongiform encephalopathy (BSE). 1. Onset and distribution of disease-specific PrP accumulation in brain and viscera. J Comp Pathol. 2001;124:280–289.
    1. Foster JD, Parnham DW, Hunter N, Bruce M. Distribution of the prion protein in sheep terminally affected with BSE following experimental oral transmission. J Gen Virol. 2001;82:2319–2326.
    1. Castilla J, Gutierrez Adan A, Brun A, Pintado B, Ramirez MA, et al. Early detection of PrPres in BSE-infected bovine PrP transgenic mice. Arch Virol. 2003;148:677–691.
    1. Beringue V, Bencsik A, Le Dur A, Reine F, Lai TL, et al. Isolation from cattle of a prion strain distinct from that causing bovine spongiform encephalopathy. PLoS Pathog. 2006;2:e112.
    1. Feraudet C, Morel N, Simon S, Volland H, Frobert Y, et al. Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cells. J Biol Chem. 2005;280:11247–11258.
    1. Andreoletti O, Lacroux C, Chabert A, Monnereau L, Tabouret G, et al. PrP(Sc) accumulation in placentas of ewes exposed to natural scrapie: influence of foetal PrP genotype and effect on ewe-to-lamb transmission. J Gen Virol. 2002;83:2607–2616.
    1. Fraser H, Dickinson AG. The sequential development of the brain lesion of scrapie in three strains of mice. J Comp Pathol. 1968;78:301–311.
    1. Castilla J, Gutierrez-Adan A, Brun A, Doyle D, Pintado B, et al. Subclinical bovine spongiform encephalopathy infection in transgenic mice expressing porcine prion protein. J Neurosci. 2004;24:5063–5069.
    1. Bencsik A, Baron T. Bovine spongiform encephalopathy agent in a prion protein (PrP)ARR/ARR genotype sheep after peripheral challenge: complete immunohistochemical analysis of disease-associated PrP and transmission studies to ovine-transgenic mice. J Infect Dis. 2007;195:989–996.
    1. Cooper JK, Ladhani K, Minor PD. Reference materials for the evaluation of pre-mortem variant Creutzfeldt-Jakob disease diagnostic assays. Vox Sang. 2007;92:302–310.

Source: PubMed

3
Prenumerera